Autoavaliação de Sintomas pelo Paciente com Câncer: a Hora é Agora
DOI:
https://doi.org/10.32635/2176-9745.RBC.2022v68n4.2733Palavras-chave:
medidas de resultados relatados pelo paciente, antineoplásicos, neoplasias, assistência centrada no pacienteResumo
O artigo descreve conceitos e evidências baseados na literatura científica e opiniões de profissionais que atuam com pacientes com câncer sobre um instrumento de autorrelato de sinais e sintomas. O PRO-CTCAE® é um instrumento utilizado no cuidado ao paciente com câncer com o objetivo de empoderar o paciente na tomada de decisão quanto ao planejamento e monitoramento do seu tratamento, evidenciar sintomas até então não questionados ou valorizados, qualificar a comunicação entre o paciente e os profissionais de saúde, refletindo as metas das estratégias globais para o controle das doenças crônicas.
Downloads
Referências
World Health Organization. WHO report on cancer: setting priorities, investing wisely and providing care for all [Internet]. Geneva: WHO; 2020 [cited 2022 May 5]. Available from: https://www.who.int/publications/i/item/9789240001299
Alcaraz KI, Wiedt TL, Daniels EC, et al. Understanding and addressing social determinants to advance cancer health equity in the United States: a blueprint for practice, research, and policy. CA Cancer J Clin. 2020;70(1):31-46. doi: https://doi.org/10.3322/caac.21586
Oldenmenger WH, Geerling JI, Mostovaya I, et al. A systematic review of the effectiveness of patient-based educational interventions to improve cancer-related pain. Cancer Treat Rev. 2018;63:96-103. doi: https://doi.org/10.1016/j.ctrv.2017.12.005
Pan American Health Organization. Innovative care for chronic conditions: organizing and delivering high quality care for chronic noncommunicable diseases in the Americas. Washington (DC): PAHO; 2013 [cited 2022 May 5]. Available from: https://www.paho.org/hq/dmdocuments/2013/PAHO-Innovate-Care-2013-Eng.pdf
Schmidt T, Valuck T, Perkins B, et al. Improving patient-reported measures in oncology: a payer call to action. J Manag Care Spec Pharm. 2021;27(1):118-26. doi: https://doi.org/10.18553/jmcp.2020.20313
Basch E, Reeve BB, Mitchell SA, et al. Development of the National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). J Natl Cancer Inst. 2014;106(9):dju244 doi: https://doi.org/10.1093/jnci/dju244
Atkinson TM, Ryan SJ, Bennett AV, et al. The association between clinician-based common terminology criteria for adverse events (CTCAE) and patient-reported outcomes (PRO): a systematic review. Support Care Cancer. 2016;24(8):3669-76. doi: https://doi.org/10.1007/s00520-016-3297-9
Kluetz PG, Chingos DT, Basch EM, et al. Patient-Reported Outcomes in cancer clinical trials: measuring symptomatic adverse events with the National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). Am Soc Clin Oncol Educ Book. 2016;35:67-73. doi: https://doi.org/10.1200/EDBK_159514
Budhwani S, Wodchis WP, Zimmermann C, et al. Self-management, self-management support needs and interventions in advanced cancer: a scoping review. BMJ Support Palliat Care. 2018;9(1):12-25. doi: https://doi.org/10.1136/bmjspcare-2018-001529
Kim J, Singh H, Ayalew K, et al. Use of PRO measures to inform tolerability in oncology trials: implications for clinical review, IND safety reporting, and clinical site inspections. Clin Cancer Res. 2018;24(8):1780-84. doi: https://doi.org/10.1158/1078-0432.CCR-17-2555
Wilson KA, Dowling AJ, Abdolell M, et al. Perception of quality of life by patients, partners and treating physicians. Qual Life Res. 2000;9(9):1041-52. doi: https://doi.org/10.1023/A:1016647407161
Laugsand EA, Sprangers MAG, Bjordal K, et al. Health care providers underestimate symptom intensities of cancer patients: a multicenter European study. Health Qual Life Outcomes. 2010;8:104. doi: https://doi.org/10.1186/1477-7525-8-104
Mendonza TR, Dueck AC, Bennett AV, et al. Evaluation of different recall periods for the US National Cancer Institute’s PRO-CTCAE. Clin Trials. 2017;14(3):255-63. doi: https://doi.org/10.1177/1740774517698645
Baeksted C, Pappot H, Nissen A, et al. Feasibility and acceptability of electronic symptom surveillance with clinician feedback using the Patient-Reported Outcomes version of Common Terminology Criteria for Adverse Events (PRO-CTCAE) in Danish prostate cancer patients. J Patient Rep Outcomes. 2017;1(1):1. doi: https://doi.org/10.1186/s41687-017-0005-6
Downloads
Publicado
Como Citar
Edição
Seção
Licença
Os direitos morais e intelectuais dos artigos pertencem aos respectivos autores, que concedem à RBC o direito de publicação.
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
